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CASE REPORT
PRIMARY CUTANEOUS CRYPTOCOCCOSIS DUE TO Cryptococcus neoformans var. gattii
SEROTYPE B, IN AN IMMUNOCOMPETENT PATIENT
Carlos da Silva LACAZ(1), Elisabeth Maria HEINS-VACCARI(1), Giovanna L. HERNÁNDEZ-ARRIAGADA(1), Eduardo Lacaz MARTINS(2), Célia A.L. PREARO(2),
Simone Miwa  CORIM(1) & Marilena dos Anjos MARTINS(3)
SUMMARY
The authors report a male patient, a seller with no detected immunosuppression, with an extensive ulcerated skin lesion localized
on the left forearm, caused by Cryptococcus neoformans var. gattii serotype B. Oral treatment with fluconazole was successful.
A review of the literature showed the rarity of this localization in HIV-negative patients. In contrast, skin lesions frequently occurs
in HIV-positive patients, with Cryptococcus neoformans var. neoformans serotype A predominating as the etiological agent.
In this paper, the pathogenicity of C. neoformans to skin lesions in patients immunocompromised or not, is discussed, showing
the efficacy of fluconazole for the treatment of these processes.
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INTRODUCTION
Cryptococcosis is a fungal infection caused by two varieties of
Cryptococcus neoformans, with five serotypes. We traditionally consider
the varieties C. neoformans var. neoformans (serotypes A, D and AD)
and C. neoformans var. gattii (serotypes B and C) (LACAZ et al. 1991)12.
According to some researchers, C. neoformans var. grubii represents
strains of serotype A, var. neoformans (serotypes D e AD) and var. gattii
(serotypes B and C) (FRANZOT et al., 1999)7. Based on sequential
analysis of intergenic rDNA spaces, DIAZ et al., (2001)6 consider two
pathogenic varieties: C. neoformans (serotypes A, D and AD) and C.
bacillisporus (serotypes B and C), the latter corresponding to C.
neoformans var. gattii.
 The sexual states of C. neoformans are assigned to Filobasidiella,
with the species neoformans and bacillispora. A heterothallic yeast, C.
neoformans presents two types of conjugating hyphae:  and a (KWON-
CHUNG & BENNETT, 1992; TAKEO et al. 1993)10,25.
A capsulated yeast, C. neoformans (SANFELICE, 1894) Vuillemin,
1901 can be isolated in a relatively easy manner, making possible the
study of its sexuality and of its antigenic and genetic structure.
Current research has been mainly directed at the study of the genome
of C. neoformans, its life cycle and ecological niche (LAZERA et al.,
2000; MONTENEGRO & PAULA, 2000)13,17.
C. neoformans var. gattii has been isolated in Brazil by several
investigators, mainly from hollow trees (LAZERA et al., 2000)13 but
also from soil and plant detritus (LAZERA et al., 1998)14.
BARRETO DE OLIVEIRA (2001)2 observed that 40 of 58 serotyped
strains (70%) were serotype A, 10 (17%) serotype B, 5 (8%) serotype D,
2 (3%) serotype C, and 1 (2%) serotype AD. C. neoformans var.
neoformans serotype A predominates in Brazil, followed by the variety
gattii, serotype B at lower frequency.
Cryptococcosis has been reported to be associated with AIDS in
most cases, or with other immunodeficiencies, being rarely observed in
immunocompetent patients (KWON-CHUNG & BENNETT, 1992;
SPEED & DUNT, 1995)10,24. According to SEVERO et al. (1999)23,
cryptococcosis induced by C. neoformans var. neoformans usually occurs
in immunocompromised patients and C. neoformans var. gattii occurs
in immunocompetent subjects.
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In a study on immunosuppressed Wistar rats, ALMEIDA FILHO
(2001)1 observed that C. neoformans var. neoformans, serotype A, is
more virulent to these animals than var. gattii, serotype B.
MITCHELL & PERFECT (1995)16, in a review of cryptococcosis
during the AIDS era, reported that this fungal infection is causing great
suffering to mankind.
CASE REPORT
T.U, patient attended in the Faculty of Medicine of ABC, Santo
André, São Paulo, 65 years old, a male seller borned in Japan and living
in São Bernardo do Campo, presented an extensive ulceration with
erythematous borders and irregular infiltrates on the left forearm starting
50 days before his consultation (Fig. 1). According to the patient, the
lesion had started with a macula that progressed to ulceration.
The culture of the lesion was positive for Cryptococcus neoformans
var. gattii, serotype B (Fig. 2). Histopathological examination was positive
for C. neoformans (mucicarmin method) (Fig. 3). A chest X-ray was
normal. A search for anti-HIV antibodies was negative. Blood count
and cerebrospinal fluid were normal. A latex test applied to serum for
the detection of circulating Cryptococcus neoformans antigen was
positive. Skull tomography showed no alterations and digestive
tomography revealed mild erosive gastritis. Glucose: 70 mg/dL;
Creatinine: 0.8 mg/dL. Treatment with fluconazole, 150 mg/3 capsules
a day, led to a complete cure within 45 days (Fig. 4).
DISCUSSION
Cutaneous cryptococcosis in its generalized forms, especially in
patients with AIDS, presents multiple lesions, most of them simulating
molluscum contagiosum. Acneiform, nodular, or herpetiform lesions,
or cellulitis are frequently recorded (LACAZ et al., 1991; RICCHI et
al., 1991; MANRIQUE et al., 1992)12,15,20. HECKER & WEINBERG
(2001)9 recorded one case of cutaneous cryptococcosis simulating a
cheloid in a man with AIDS.
Fig. 1 - Left forearm with an extensive ulceration with erythematous borders and irregular
infiltrates.
Fig. 3 - Histopathological slides positive for C. neoformans (mucicarmin methd, 500x).
Fig. 4 - Left forearm after 45 days therapy.
Fig. 2 - C. neoformans var. gattii – Culture on Sabouraud dextrose agar, incubated at 25 °C,
3 days.
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In the case described here, a hypothesis that might be raised is that
the site of entry of the fungus was by inhalation of small yeast propagula,
probably its basidiospores, that were first installed in the lungs and were
radiologically undetectable, followed by skin lesion (KWON-CHUNG
& BENNETT, 1992)10. Direct examination of biopsy with a drop of
India ink, showed yeast cells with capsules. The fungus isolated from
the lesion was identified as C. neoformans var. gattii, serotype B.
The literature reports marked dermotropism of the so-called grubii
variety of C. neoformans, serotype A (FRANZOT et al., 1999)7. We
should point out the absence of trauma preceding the lesion and of any
detected immunosuppression.
According to RODRIGUES et al. (1999)21, when the host is
immunocompromised, C. neoformans cells try to escape the defenses of
the organism by producing sialic acid, capsulated polysaccharides,
melanin, mannitol and phospholipase. In contrast, in immunocompetent
hosts the mechanisms of pathogenicity have not been carefully clarified.
In cryptococcosis, melanin seems to interfere with the virulence of the
yeast, with great tropism for the central nervous system, rich in
catecholamines.
PAPPAS et al. (2001)18 conducted a review study in the United States
involving 15 American Medical Centers from 1990 to 1996 and a total
of 306 patients with cryptococcosis, all of them HIV negative. Of these,
109 presented pulmonary lesions, 157 central nervous system lesions,
and 40 lesions located at other sites. Fluconazole was administered to
approximately 2/3 of the patients, with therapeutic success in 74% of
them.
BOHNE et al. (1996)3 reported an erysipela-like lesion induced by
C. neoformans in a female patient with sarcoidosis after a traumatic
injury, which was treated with corticoids. This patient was treated
successfully with itraconazole.
HAMANN et al. (1997)8, in Australia, reported an immunocompetent
patient with cellulitis induced by C. neoformans var. gattii.
PATEL et al. (2000)19 reported a case of cutaneous cryptococcosis
involving an immunocompetent elderly woman (85 years of age) induced
by C. neoformans which was cured with fluconazole.
VELEGRAKI et al. (2001)26, in Greece, reported two cases of
cryptococcosis induced by C. neoformans var. gattii serotype B, one
involving an HIV-positive patient and the other a patient with systemic
lupus erythematosus.
SEVERO et al. (1999)23 in Rio Grande do Sul (Brazil), reported
three cases of cryptococcosis induced by C. neoformans var. gattii,
affecting HIV-positive patients. SEVERO et al. (2001)22 also reported a
case of cutaneous cryptococcosis induced by C. neoformans var. gattii
in an immunocompetent host.
In Teresina (Piauí), C. neoformans var. gattii is the causal agent of
cryptococcosis in 91.2% of HIV-negative patients (CAVALCANTI,
1997)4. This variety has been found in Belém (Pará) as an agent of
pediatric neurocryptococcosis (CORRÊA, 2001)5.
In Brazil, the serotypes of C. neoformans strains predominantly
belongs to A, followed by B (LACAZ & RODRIGUES, 1983)11. For the
patient reported here, we emphasize the excellent therapeutic result
obtained after 45 days of fluconazole treatment.
RESUMO
Criptococose cutânea primária causada por Cryptococcus
neoformans var. gattii sorotipo B em paciente
imunocomprometido
Os autores registram em paciente do sexo masculino, vendedor
ambulante sem qualquer doença de base, lesão cutânea extensa, localizada
no antebraço esquerdo, sob forma ulcerada, provocada pelo Cryptococcus
neoformans var. gattii sorotipo B. Sucesso terapêutico com fluconazol,
por via oral.
Revisão da literatura foi realizada, mostrando raridade de tal
localização em pacientes HIV-negativos. Já em pacientes HIV-positivos,
lesões cutâneas ocorrem com freqüência, predominando como agente
etiológico o Cryptococcus neoformans var. neoformans, sorotipo A.
A patogenicidade do C. neoformans nas lesões cutâneas é discutida
em pacientes imunocomprometidos ou não, mostrando a eficácia do
fluconazol no tratamento de tais processos.
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